Carregant...
Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is a critical problem with an impact on both oncological and cardiovascular prognosis, especially when it prevents patients from receiving cancer treatment. Standard therapy for heart failure (HF) is recommended for CTRCD, but th...
Guardat en:
Autors principals: | , , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
BMC
2020-11-01
|
Col·lecció: | Cardio-Oncology |
Matèries: | |
Accés en línia: | http://link.springer.com/article/10.1186/s40959-020-00078-4 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|